Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MSMB
REST API REST API
Homo sapiens
MSMB is differentially expressed in 171 experiments: 107 organism parts: prostate, lung, ... (105 more);, 69 disease states: normal, prostate carcinoma, ... (67 more);, 27 cell types 135 cell lines 30 compound treatments and 54 other conditions.
Synonyms PSP, PRPS, PN44, MSP, MSPB, PSP-94, IGBF, PSP57, PSP94
Orthologs Msmb (Mus musculus)   MSMB (Gallus gallus)   Msmb (Rattus norvegicus)   msmb.3 (Xenopus laevis)   msmb.1 (Xenopus laevis)   MSMB (Bos taurus)   (Compare orthologs)
Gene Ontology Term extracellular space, extracellular region, biological_process, molecular_function, nucleus
InterPro Term PSP94
UniProt Accession B2R597, P08118
Gene-Disease Assocation PROSTATE CANCER, HEREDITARY, 13; HPC13
Search EB-eye ENSG00000138294
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-AFMX-5, E-MEXP-1251, E-GEOD-1577, ... (20 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-14464, E-GEOD-19639, E-GEOD-2450, ... (22 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-5823, E-GEOD-20081, E-GEOD-19639, E-GEOD-3529
BT-474
2
E-GEOD-5823, E-GEOD-3529
HCC1195
2
E-MTAB-62, E-GEOD-4342
MCF7
2
E-GEOD-5258, E-MTAB-37
PC3
2
E-GEOD-14464, E-GEOD-5258
SNU423
1
E-MTAB-37
129 more value(s).


Cell type

studied in E-GEOD-18811, E-MTAB-25, E-GEOD-3920, E-TABM-130, E-GEOD-13909, ... (18 experiments)

Factor Value U/D Experiments
whole blood
1
E-GEOD-3026
naive B cell
1
E-TABM-702
ADC
1
1
E-GEOD-19188
primary T lymphocytes
1
E-GEOD-13909
secretory cell
1
E-GEOD-3998
leydig cell
1
E-MTAB-25
21 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-2466, E-GEOD-1869, E-GEOD-1577, ... (34 experiments)

Factor Value U/D Experiments
prostate carcinoma
3
E-GEOD-7307, E-GEOD-96, E-MEXP-1327
benign prostatic hyperplasia
2
E-GEOD-7307, E-MEXP-1243
lung adenocarcinoma
2
E-MTAB-62, E-MTAB-37
gulf war illness
1
E-MEXP-2069
lung carcinoma
1
E-MTAB-37
prostate adenocarcinoma
1
E-GEOD-3868
63 more value(s).


Compound treatment

studied in E-GEOD-5824, E-GEOD-6462, E-GEOD-4006, E-GEOD-20719, E-MEXP-1269, ... (14 experiments)

Factor Value U/D Experiments
none
1
3
E-GEOD-412, E-GEOD-2292, E-GEOD-20719, E-GEOD-5824
control - interferon-gamma
1
E-GEOD-7216
keratinocyte growth factor
1
E-GEOD-7216
4-hydroxytamoxifen
1
1
E-MEXP-2241
ethanol
1
E-MEXP-2241
sapphyrin PCI-2054
1
E-GEOD-6400
24 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-GEOD-994, ... (10 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-1614, E-MEXP-2359, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-1561, E-TABM-147, E-GEOD-3013

Environmental stress
studied in E-GEOD-1643

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Estrogen receptor status
studied in E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genotype
studied in E-GEOD-2466, E-MEXP-421, E-GEOD-2292, E-TABM-321, E-TABM-868, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-127, E-GEOD-22278

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-GEOD-974, E-GEOD-1926, E-MEXP-2069, E-GEOD-10433, ... (26 experiments)

Infection
studied in E-GEOD-2405, E-MEXP-561

Injury
studied in E-GEOD-19743

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-AFMX-1

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-1493, E-GEOD-21750

Population
studied in E-GEOD-4922

Protocol type
studied in E-GEOD-3254, E-GEOD-19445, E-GEOD-19246

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr ereg dct
studied in E-GEOD-5851

RNAi
studied in E-GEOD-12438, E-MEXP-101

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

Sex
studied in E-GEOD-2466, E-GEOD-7307

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 00 005
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271, E-GEOD-4922

Tumor size
studied in E-GEOD-3494, E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.368 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM